Top health accelerator, Dreamit Health recently selected Epharmix and six additional new companies to join its 2018 cohort. The new companies have developed innovative technology …
Health care providers managing patients with chronic disease recognize the need for long-term patient engagement strategies to improve compliance with therapy and treatments in between …
In a recently published study in Nature Scientific Reports, researchers from Washington University in St. Louis School of Medicine and Saint Louis University School of …
Medication adherence leads to better health outcomes and healthcare cost savings, yet patients often do not complete therapy. Every patient faces unique challenges, so the reasons …
On April 10th, 2017, Epharmix CEO Blake Marggraff and Ascension CEO Anthony Tersigni participated in the first #CEO2CEO Conversation Series of the year sponsored by …
Copyright © 2019 | WordPress Theme by MH Themes